Gsk (GSK) EV to EBIT (2009 - 2026)
Gsk's EV to EBIT was 5.81 in the quarter ended Sep 30, 2026, down 34.9% from 8.92 a year earlier and down 4.7% from the prior quarter.
Powered by 
Analysis
Gsk (GSK) EV to EBIT (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Gsk's EV to EBIT was 5.03 through Sep 30, 2026, down 31.4% year-over-year; for the year ended Dec 31, 2025, it was 9.62, down 26.5% from the prior year.
- In earlier years, EV to EBIT was 13.10 in the year ended Dec 31, 2024 (+45.8%), 8.99 in the year ended Dec 31, 2023 (+1.4%), 8.86 in the year ended Dec 31, 2022 (-45.6%) and 16.29 in the year ended Dec 31, 2021 (+58.2%).
- Quarterly EV to EBIT has moved between 5.15 (the quarter ended Dec 31, 2025) and 16.87 (the quarter ended Sep 30, 2024) over five years.
- Compared with a year earlier, EV to EBIT has declined for five straight quarters, with an average decline of 22.5% over the last eight quarters.
- The best year-over-year quarter for EV to EBIT over five years was the quarter ended Sep 30, 2024 (growth of 126.4%); the worst was the quarter ended Dec 31, 2025 (a decline of 60.9%).
- Per Business Quant data, GSK's EV to EBIT in the three quarters before the quarter ended Sep 30, 2026 was 6.09 (quarter ended Jun 30, 2026), 5.75 (quarter ended Mar 31, 2026) and 5.15 (quarter ended Dec 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.17 Bn | 1,237.79 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 660.04 Bn | 579.90 Bn | 17.30 Bn |
| 3 | AbbVie | 521.06 Bn | 494.17 Bn | 12.70 Bn |
| 4 | Merck | 370.60 Bn | 370.60 Bn | - |
| 5 | Novartis Ag | 311.97 Bn | 285.20 Bn | - |
| 6 | Astrazeneca | 288.69 Bn | 262.37 Bn | 12.86 Bn |
| 7 | Amgen | 252.29 Bn | 207.69 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 213.47 Bn | 213.47 Bn | - |
| 9 | Pfizer | 173.68 Bn | 120.32 Bn | 10.94 Bn |
| 10 | Gsk | 100.27 Bn | 83.11 Bn | 8.73 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.81 |
| Jun 30, 2026 | 6.09 |
| Mar 31, 2026 | 5.75 |
| Dec 31, 2025 | 5.15 |
| Sep 30, 2025 | 8.92 |
| Jun 30, 2025 | 11.66 |
| Mar 31, 2025 | 12.84 |
| Dec 31, 2024 | 13.19 |
| Sep 30, 2024 | 16.87 |
| Jun 30, 2024 | 10.98 |
| Mar 31, 2024 | 11.37 |
| Dec 31, 2023 | 8.99 |
| Sep 30, 2023 | 7.45 |
| Jun 30, 2023 | 8.18 |
| Mar 31, 2023 | 9.67 |
| Dec 31, 2022 | 8.79 |
| Sep 30, 2022 | 9.04 |
| Jun 30, 2022 | 13.35 |
| Mar 31, 2022 | 13.72 |
| Dec 31, 2021 | 16.23 |
API Access
Gsk EV to EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebit", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();